Moody's Ratings (Moody's) assigned ratings to the proposed new debt instruments of Organon & Co. ("Organon") including a Ba1 to a new senior secured first lien term loan B, senior secured first lien revolving credit facility and secured notes, and a B1 rating to new senior unsecured notes. There are...
Moody's Ratings (Moody's) affirmed the ratings of Organon & Co. ("Organon") including the Ba2 Corporate Family Rating (CFR), the Ba2-PD Probability of Default Rating (PDR), the Ba2 senior secured credit facility ratings and notes, and the B1 senior unsecured rating. At the same time, Moody's upgrade...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.
Constellation Brands (STZ) has transformed its profitability profile through its massive expansion in the beer market and move to premiumization over the last seven years. Uniform Accounting highlights that the market is pricing in a reversal of recent profitability expansion and below-average growth, but management is confident about executing on their strategy and is aligned to continue to do so, signaling the potential for equity upside as the company continues executing. Constellation has c...
Organon & Co. (OGN) currently trades below corporate averages relative to Uniform earnings, with a 4.5x Uniform P/E (Fwd. V/E'). At these levels, markets are pricing in expectations for Uniform ROA to fade from 49% in 2021 to 9%, accompanied by 3% Uniform asset growth. Meanwhile, analysts expect Uniform ROA to fade to 38% in 2023, accompanied by 13% Uniform asset growth. If sustained going forward, these levels would imply a stock price closer to $225, representing significant potential equit...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.